26 July 2020 : Clinical Research
Is Noninvasive Prenatal Screening Appropriate for Pregnant Women Age 35 or Older In Cases if Isolated Fetal Nasal Bone Abnormalities in The Chinese Han Population?
Yuan Chen1ACDEF, Min Lv1ABEF, Tian Dong1BC, Qinqing Chen1BC, Yeqing Qian2AD, Baihui Zhao1ADFG, Qiong Luo1ADEFG*DOI: 10.12659/MSM.924387
Med Sci Monit 2020; 26:e924387
Table 3 Cost-effectiveness ratio of two screening strategies in pregnant women older than 35.
| strategies | Costs (USD) | Effectiveness (CA detected) | Cost per CA detected (USD) |
|---|---|---|---|
| Contingent screening strategy | 63143.74 | 8 | 7893.86 |
| Invasive diagnostic test | 170999.41 | 8 | 21377.34 |
| CA – chomosomal abnormalities. The costs were calculated based on pregnant women older than 35(n=394). The cost of invasive diagnostic test was calculated as karyotyping or CMA. | |||